COMMUNIQUÉS West-GlobeNewswire

Ceapro Inc. to Present at the Fall Investor Summit in New York
10/09/2019
Presentation with live audio webcast Monday, September 16th at 2:30 PM EDT EDMONTON, Alberta, Sept. 10, 2019 (GLOBE NEWSWIRE) -- Ceapro Inc. ( TSX-V: CZO) (“Ceapro” or the “Company”) , a growth-stage biotechnology [...]
TRHC and Troy Medicare Leverage Technology to Provide Innovative Care Coordination
10/09/2019
Partnership focuses on care and cost in health plans MOORESTOWN, N.J. and CHARLOTTE, N.C., Sept. 10, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. ("TRHC") (NASDAQ:TRHC), a leading provider of technology-enabled [...]
Syapse Appoints Fletcher Payne as Chief Financial Officer
10/09/2019
Life sciences veteran brings 25 years of experience leading the financial, commercial and business operations of growth-oriented, global healthcare and technology businesses SAN FRANCISCO, Sept. 10, 2019 (GLOBE NEWSWIRE [...]
Nkarta Therapeutics Appoints Vice President of Regulatory Affairs
10/09/2019
SOUTH SAN FRANCISCO, Calif., Sept. 10, 2019 (GLOBE NEWSWIRE) -- Nkarta Therapeutics, a privately-held biopharmaceutical company developing engineered natural killer (NK) cell therapies to fight cancer, today announced [...]
Nu-Med Plus Accelerates FDA Submission in Light of Patent Ruling
10/09/2019
SALT LAKE CITY, Sept. 10, 2019 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc . (OTCQB: NUMD), a medical device developer of new nitric oxide delivery technology announced that it will be accelerating the FDA submission of its [...]
Biotricity CEO Waqaas Al-Siddiq in Live Interview on FOX Business Network
10/09/2019
Wearable Expert to Discuss Economic Impact on U.S. Medical Device Companies on Wednesday, September 11 at 3:15pm REDWOOD CITY, Calif., Sept. 10, 2019 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY ), today announced [...]
iCAD’s ProFound AI Reader Study Published in Radiology: Artificial Intelligence
10/09/2019
First and Only FDA-Cleared Digital Breast Tomosynthesis Software with Artificial Intelligence Clinically Proven to Enhance Breast Cancer Screening, Reduce False Positives and Slash Reading Time for Radiologists in Half [...]
Protech Home Medical Provides Corporate Update
10/09/2019
Non-Core Asset Sale, Return of Stolen Funds and Executive Team Expansion Allow the Company to Accelerate its Growth NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE ‎UNITED STATES [...]
Vystar’s Securities to Begin Trading on OTCQB Sept. 10
10/09/2019
WORCESTER, Mass., Sept. 10, 2019 (GLOBE NEWSWIRE) -- Vystar Corp. (OTCQB: VYST) is approved to have its securities trade on the OTCQB marketplace, effective September 10, 2019. All classes of Vystar’s securities that [...]
Eloxx Pharmaceuticals to Participate in the Oppenheimer Fall Summit Focused on Specialty Pharma & Rare Diseases on September 24, 2019
10/09/2019
WALTHAM, Mass., Sept. 10, 2019 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat cystic [...]
Intra-Cellular Therapies Provides Lumateperone Regulatory Update
10/09/2019
FDA has informed the Company it has no plans to schedule an Advisory Committee Meeting Company has completed submission of non-clinical information previously agreed with FDA NEW YORK, Sept. 10, 2019 (GLOBE NEWSWIRE [...]
Fluidigm Files Patent Infringement Suit Against IONpath
10/09/2019
SOUTH SAN FRANCISCO, Calif., Sept. 10, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today [...]
CellCentric starts dosing patients in blood cancer trial, expanding clinical testing of CCS1477
10/09/2019
CellCentric starts dosing patients in blood cancer trial, expanding clinical testing of CCS1477 CCS1477 is the first drug to be used in patients that specifically targets p300/CBP, offering a new route to treat specific [...]
Nordic Transport Group announces intention to launch an indirect public offering through NeuroSearch on Nasdaq Copenhagen
10/09/2019
Company announcement no 23 - 19 10 September 2019 NOT FOR RELEASE OR DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER [...]
Santhera Announces Publication of Phase I Clinical Data with POL6014 in Journal of Cystic Fibrosis
10/09/2019
Pratteln, Switzerland, September 10, 2019 – Santhera Pharmaceuticals (SIX: SANN) announces the online publication of Phase I data with its human neutrophil elastase (hNE) inhibitor POL6014 in the Journal of Cystic [...]
Roche presents new OCREVUS (ocrelizumab) biomarker data that increase understanding of disease progression in multiple sclerosis at ECTRIMS
10/09/2019
Roche presents new OCREVUS (ocrelizumab) biomarker data that increase understanding of disease progression in multiple sclerosis at ECTRIMS Blood neurofilament light chain (NfL) levels were significantly lowered [...]
Kiadis Pharma announces results for the six months ended June 30, 2019
10/09/2019
Kiadis to hold conference call with investors today at 15:00 CEST Amsterdam, The Netherlands, September 10, 2019 – Kiadis Pharma N.V. (“Kiadis Pharma” or the “Company”) (Euronext Amsterdam and Brussels: KDS) , a [...]
Dr. Gregory Jantz is proud to inform you of his new book – Healing Depression for Life
10/09/2019
Gregory Jantz is the Founder of The Center • A Place of HOPE Edmonds, WA, Sept. 09, 2019 (GLOBE NEWSWIRE) -- It is with great honor that Dr. Gregory Jantz is announcing the release of his latest book titled, Healing [...]
Mesoblast Corporate Update: Analyst Call
10/09/2019
NEW YORK, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in cellular medicines for inflammatory diseases, will provide a corporate update during an analyst call today. The [...]

Pages